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INTRODUCTION
A standard Wise-pattern reduction can be used to excise
a breast cancer that falls within the Wise pattern.1 When
the tumor is located outside the Wise pattern, it can be
removed by tunneling and pulling the lesion through the
Wise-pattern incision. When it is necessary to take skin
overlying the tumor, the Wise pattern can be reconfigured
by moving either the lower inner or lower outer quadrant
triangles, which are a normal part of the standard Wise
pattern, to a position over the tumor. This change must be
accompanied by splitting the vertical limb of the reduction
to accommodate the repositioning of the triangle, a tech-
nique known as split reduction.2 This alteration in the Wise
pattern removes the skin directly over the tumor and
guarantees that the anterior margin will be clear.
Intraoperative radiation therapy (IORT) is a technique
used for administering a single dose of radiation therapy
given during a ‘lumpectomy’ procedure. Two prospective,
randomized trials have shown that, in selected low-risk
patients, IORT may be adequate as the entire course of
radiation therapy.3,4 In this video, we combined IORT with
a split reduction tumor excision.
METHODS
The patient in this video presented with a right upper
outer quadrant needle biopsy-proven invasive ductal car-
cinoma. The split reduction was designed by moving the
lower outer quadrant triangle of a standard Wise pattern
superiorly so that it overlaid the tumor. The right vertical
limb was split into two sections to accommodate this
change.
For IORT, a Xoft Axxent that delivered 20 Gy to the
surface of the IORT balloon was used. IORT criteria at
our facility included age C48 years, preoperative MRI,
ultrasound and digital mammography in all patients, and
tumor span by all imaging B30 mm. At final pathology,
tumor extent must be B30 mm, all margins must be
C2 mm, and the sentinel node must be negative. If all of
the criteria are not met, IORT becomes the boost and the
patient receives 5 weeks of whole-breast irradiation.
Patient satisfaction surveys were completed after 1 month,
6 months and 1 year of follow-up.
RESULTS
Overall, 110 patients were treated with the combination
of reduction excision plus IORT. Clear margins using no
ink on tumor as the definition were achieved in 97 % of
cases, and when 2 mm was used as the definition, clear
margins were achieved in 88 % of cases. Forty patients
failed one or more of our IORT criteria, 28 of whom agreed
to undergo supplemental whole-breast irradiation. Two
patients (1.8 %) opted for mastectomy rather than addi-
tional radiation therapy, five (4.5 %) underwent re-
excision, and five declined additional local therapy. Only
one local recurrence has been observed, which was outside
the IORT field, but follow-up was short (average
21 months) since this is a new program. Side effects were
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minimal. Ninety-eight percent of patients who answered
the patient satisfaction survey after 1 year of follow-up
said they would choose to have IORT again. Patient
characteristics are shown in Table 1.
CONCLUSIONS
The combination of reduction excision plus IORT works
well. In this series, 68 % of patients received all of their
local treatment during a single operative procedure. This is
profoundly convenient. Reduction excision allows the
widest possible excision of the tumor while at the same
time achieving excellent cosmetic results.1,2 IORT is cap-
able of delivering the entire course of radiation therapy in a
single setting in selected low-risk patients. Should there be
a local recurrence, it can be re-excised and whole-breast
irradiation can be given at that time. Patient satisfaction is
extremely high with the combination of reduction excision
and IORT.
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TABLE 1 Patient characteristics (n = 110)
Average age (years) 62
Average tumor size, mm (largest invasive component) 18
Average tumor span, mm (includes all components
of the disease)
22
Average specimen weight (g) 144
Average margin width (mm) 6.9
Failed one or more IORT criteria 40 (36 %)
Margins\2 mm 12 (11 %)
No ink on tumor 3 (2.7 %)
Underwent re-excision 5 (4.5 %)
Received whole-breast RT 28 (25 %)
Converted to mastectomy 2 (1.8 %)
Recurrence inside IORT field 0 (0 %)
Recurrence outside IORT field 1 (0.9 %)
Hematomas that required drainage 2 (1.8 %)
Chronic seroma 0 (0 %)
Chronic hyperpigmentation 6 (5.5 %)
Data are expressed as n (%) unless otherwise specified
IORT intraoperative radiation therapy, RT radiation therapy
3406 M. J. Silverstein et al.
